Insights

Vicore Pharma Holding AB

Nasdaq Stockholm · LEI 549300KTNBPTZLF01130· Fiscal year 2025

Staff cost per employee
Not disclosed
Employees
Not disclosed

Quick read

  • Revenue fell 96.5% year over year.
  • Operating loss of $44.4M in 2025.

Last 3 years

Revenue
$10.7M2024$374.9K2025
Operating income
-$19.1M2024-$44.4M2025

See the share price on Google Finance ↗

Investor metrics

2025
Operating margin
-11851.9%
Net margin
-12509.1%
ROE
-43.6%
Debt-to-equity
11.2%
Equity ratio
89.9%

USD at SEK 10.18 per $1 (2026-11-20, ExchangeRate-API)

Staff costs from the annual report (wages, social charges, pensions) divided by the average number of employees. Usually higher than take-home pay.

audited consolidated financial statements · View the annual report (filings.xbrl.org)

Not investment advice. Figures come from public filings and may contain errors.